RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER Read more about RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US Application 63/070,739Filed on 2020-08-26
Ex-miRNAs As Nerve Injury And Neuropathic Pain Biomarkers Read more about Ex-miRNAs As Nerve Injury And Neuropathic Pain Biomarkers US Application 63/040,964Filed on 2020-06-18
Optimization Of Lead Small Molecule Inhibitors Of Taspase1 For Cancer Therapeutics Read more about Optimization Of Lead Small Molecule Inhibitors Of Taspase1 For Cancer Therapeutics US Application 62/939,258Filed on 2019-11-22
PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Read more about PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER US Application 63/082,813Filed on 2020-09-24
TYROSYL-LOCK PEPTIDES Read more about TYROSYL-LOCK PEPTIDES US Application 63/115,418Filed on 2020-11-18
RNASEH-ASSISTED DETECTION ASSAY FOR RNA (RADAR) Read more about RNASEH-ASSISTED DETECTION ASSAY FOR RNA (RADAR) US Application 63/077,123Filed on 2020-09-11
LZK-TARGETING DEGRADERS AND METHODS OF USE Read more about LZK-TARGETING DEGRADERS AND METHODS OF USE US Application 63/073,835Filed on 2020-09-02
Synthetic Lethality-mediated Precision Oncology Via The Tumor Transcriptome Read more about Synthetic Lethality-mediated Precision Oncology Via The Tumor Transcriptome US Application 63/107,737Filed on 2020-10-30
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US Application 63/060,340Filed on 2020-08-03
HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION Read more about HLA CLASS II-RESTRICTED DQ T CELL RECEPTORS AGAINST RAS WITH G13D MUTATION US Application 63/086,674Filed on 2020-10-02